Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gauvin

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Chemical Communications (Cambridge, England)|March 3, 2011
An easily accessible Re-based catalyst for the selective conversion of methanol: evidence for an unprecedented active site structure through combined operando techniquesAnthony Yoboué, Audrey Susset, Asma Tougerti, et al.
Bioorganic & Medicinal Chemistry|June 24, 2010
Synthesis and biological evaluation of 5-substituted and 4,5-disubstituted-2-arylamino oxazole TRPV1 antagonistsRichard J Perner, John R Koenig, Stanley Didomenico, et al.
Journal of Medicinal Chemistry|September 20, 2002
N-[3-(1H-imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1),(1) a novel alpha(1)-adrenoceptor ligand with an enhanced in vitro and in vivo profile relative to phenylpropanolamine and midodrineRobert J Altenbach, Albert Khilevich, Michael D Meyer, et al.
Journal of Surgical Education|January 3, 2012
The certifying examination of the american board of surgery: the effect of improving communication and professional competency: twenty-year resultsPamela A Rowland, Thadeus L Trus, Nicholas P Lang, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 20, 2006
A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the ratPrisca Honore, Diana Donnelly-Roberts, Marian T Namovic, et al.
Clinical Immunology (Orlando, Fla.)|January 13, 1999
Ex vivo assessment of immunosuppression in undiluted whole blood from pigs dosed with tacrolimus (FK506)Y W Chen, M L Smith, M P Sheets, et al.
Journal of the American College of Surgeons|March 20, 2018
Comprehensive Multicenter Graduate Surgical Education Initiative Incorporating Entrustable Professional Activities, Continuous Quality Improvement Cycles, and a Web-Based Platform to Enhance Teaching and LearningCheryl I Anderson, Marc D Basson, Muhammad Ali, et al.
Pain|July 13, 2010
A-995662 [(R)-8-(4-methyl-5-(4-(trifluoromethyl)phenyl)oxazol-2-ylamino)-1,2,3,4-tetrahydronaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain modelPamela S Puttfarcken, Ping Han, Shailen K Joshi, et al.
The Journal of Investigative Dermatology|May 8, 1999
A macrolactam inhibitor of T helper type 1 and T helper type 2 cytokine biosynthesis for topical treatment of inflammatory skin diseasesK W Mollison, T A Fey, D M Gauvin, et al.
JAMA Surgery|April 30, 2021
Factors Associated With General Surgery Residents' Operative Experience During the COVID-19 PandemicAmanda C Purdy, Christian de Virgilio, Amy H Kaji, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Chemical Communications (Cambridge, England)|March 3, 2011
An easily accessible Re-based catalyst for the selective conversion of methanol: evidence for an unprecedented active site structure through combined operando techniquesAnthony Yoboué, Audrey Susset, Asma Tougerti, et al.
Bioorganic & Medicinal Chemistry|June 24, 2010
Synthesis and biological evaluation of 5-substituted and 4,5-disubstituted-2-arylamino oxazole TRPV1 antagonistsRichard J Perner, John R Koenig, Stanley Didomenico, et al.
Journal of Medicinal Chemistry|September 20, 2002
N-[3-(1H-imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1),(1) a novel alpha(1)-adrenoceptor ligand with an enhanced in vitro and in vivo profile relative to phenylpropanolamine and midodrineRobert J Altenbach, Albert Khilevich, Michael D Meyer, et al.
Journal of Surgical Education|January 3, 2012
The certifying examination of the american board of surgery: the effect of improving communication and professional competency: twenty-year resultsPamela A Rowland, Thadeus L Trus, Nicholas P Lang, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 20, 2006
A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the ratPrisca Honore, Diana Donnelly-Roberts, Marian T Namovic, et al.
Clinical Immunology (Orlando, Fla.)|January 13, 1999
Ex vivo assessment of immunosuppression in undiluted whole blood from pigs dosed with tacrolimus (FK506)Y W Chen, M L Smith, M P Sheets, et al.
Journal of the American College of Surgeons|March 20, 2018
Comprehensive Multicenter Graduate Surgical Education Initiative Incorporating Entrustable Professional Activities, Continuous Quality Improvement Cycles, and a Web-Based Platform to Enhance Teaching and LearningCheryl I Anderson, Marc D Basson, Muhammad Ali, et al.
Pain|July 13, 2010
A-995662 [(R)-8-(4-methyl-5-(4-(trifluoromethyl)phenyl)oxazol-2-ylamino)-1,2,3,4-tetrahydronaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain modelPamela S Puttfarcken, Ping Han, Shailen K Joshi, et al.
The Journal of Investigative Dermatology|May 8, 1999
A macrolactam inhibitor of T helper type 1 and T helper type 2 cytokine biosynthesis for topical treatment of inflammatory skin diseasesK W Mollison, T A Fey, D M Gauvin, et al.
JAMA Surgery|April 30, 2021
Factors Associated With General Surgery Residents' Operative Experience During the COVID-19 PandemicAmanda C Purdy, Christian de Virgilio, Amy H Kaji, et al.
Pageof 11